Toshiaki A. Furukawa, MD, PhD Professor
Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, promotes pragmatic and empirical research on behaviors and cognitions that bear on disease and health of humankind. Its two vehicles of research consist of cognitive-behavior therapy (CBT) and clinical epidemiology (evidence-based medicine: EBM). Students are expected to learn how to interpret and apply evidence to clinical problems in their own fields, plan and execute clinical research to answer questions not yet covered in the current literature, and ultimately to contribute to better clinical practices in the world.
Research and EducationThe research themes in the Department currently include:
1. In the field of EBM,
1.1. A pragmatic mega-trial to establish optimum treatment strategies of new generation antidepressants for major depression
1.2. Network meta-analyses of psychosocial and biological therapies for depression and panic disorder (in collaboration with the Cochrane Collaboration Depression, Anxiety and Neurosis Group)
1.3. Research and development of new methods to translate evidence into clinical practices, applying epidemiology, statistics and psychometrics.
2. In the field of CBT,
2.1. A randomized controlled trial of smartphone-based CBT
2.2. Research and development of new CBT
2.3. Research and development of CBT programs for patients with physical diseases
The Department is also a collaborator for the Master of Clinical Research program.
Recent Publications1.Furukawa TA, Watanabe N, Omori IM, et al (2007) Association between unreported outcomes and effect size estimates in Cochrane meta-analyses. JAMA, 297, 468-470.
2.Cipriani A, Furukawa TA, Salanti G, et al (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373, 746-758.
3.Furukawa TA, Levine SZ, Tanaka S, et al (2015) Initial severity of schizophrenia and efficacy of antipsychotics: Participant-level meta-analysis of six placebo-controlled studies. JAMA Psychiatry, 72, 14-21.
4.Nikolakopoulou A, Mavridis D, Furukawa TA, et al (2018) Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study. BMJ.
5.Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JP, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JP & Geddes JR (2018) Comparative efficacy and acceptability of first- and second-generation antidepressants in the acute treatment of major depressive disorder: A network meta-analysis. Lancet.
Health Promotion and Human BehaviorProfessor: Toshiaki A. Furukawa, MD, PhD
Associate Professor: Norio Watanabe, MD, PhD